Liver Metastatic Disease (LMD) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): Incidence, Treatment and Survival in a Multicenter Study in Argentina. Preliminary Report. ARGENTUM GROUP
Introduction: The first observational Study from our Group in Argentina, showed 60% incidence of liver mets at initial diagnosis. The treatment encompasses a wide scope of surgical and non-surgical modalities.
Aim(s): To assess prevalence, incidence and regional trends in management and outcomes in patients with LMD in GEP-NET.
Materials and methods: Data was registered online and assessed for internal consistency by reviewers from our working group. We included only patients with synchronous or metachronous LMD.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: O´Connor J
To read the full abstract, please log into your ENETS Member account.